Pain Management Techniques for Total Knee Replacement

Overseen by Stavros Memtsoudis, MD/PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Hospital for Special Surgery, New York

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests if delivering numbing medicine through a small tube can reduce pain and opioid use in knee replacement patients. It aims to see if this method helps manage pain better than other methods.

Research Team

Stavros Memtsoudis, MD/PhD

Principal Investigator

Hospital for Special Surgery, New York

Jashvant Poeran, MD/PhD

Principal Investigator

Hospital for Special Surgery, New York

Eligibility Criteria

This trial is for adults aged 18-75 with osteoarthritis scheduled for knee replacement surgery at certain surgeons, living within an hour of the hospital, owning a smartphone, and able to follow instructions in English. Excluded are those with general anesthesia, drug allergies, BMI >40, diabetes, severe joint deformity or contracture, chronic opioid or gabapentin use.

Inclusion Criteria

I am between 18 and 75 years old.

I am scheduled for a knee replacement surgery with a participating surgeon due to osteoarthritis.

I will be receiving regional anesthesia.

Exclusion Criteria

I have diabetes.

I have been taking gabapentin or pregabalin regularly for more than 3 months.

I will be undergoing surgery with general anesthesia.

Treatment Details

Interventions

• Adductor Canal Catheter (Procedure)
• Sham Adductor Canal Catheter (Procedure)

Trial Overview The study tests if there's a difference in opioid use after surgery between patients getting an adductor canal catheter (ACC) versus a sham catheter. It uses the Diagnotes app for communication and checks pain levels up to 6 months post-surgery.

Participant Groups

Group I: Adductor Canal Catheter (ACC) - Interventional Experimental Treatment 1 Intervention

Patients will received the an adductor canal catheter that continuously infuses numbing medication to their operative leg for 50 hours post-surgery. Patients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place.

Group II: Adductor Canal Block (ACB) - Control Placebo Group 1 Intervention

Patients will received the a sham adductor canal catheter that is attached to their operative leg for 50 hours post-surgery. Patients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place.

Who Is Running the Clinical Trial?

Hospital for Special Surgery, New York

Lead Sponsor

Trials

257

Recruited

61,800+